An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive
PfizerPfizer(US:PFE) WSJ·2026-03-23 16:46

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades. ...

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive - Reportify